Literature DB >> 7706255

Retinoic acid induction of human tissue-type plasminogen activator gene expression via a direct repeat element (DR5) located at -7 kilobases.

F Bulens1, I Ibañez-Tallon, P Van Acker, A De Vriese, L Nelles, A Belayew, D Collen.   

Abstract

All-trans-retinoic acid (RA) and retinoids induce synthesis of tissue-type plasminogen activator (t-PA) in endothelial and neuroblastoma cells in vitro and in rats in vivo. In HT1080 fibrosarcoma cells, induction of t-PA-related antigen secretion and t-PA mRNA steady state levels by RA were found to depend on de novo protein and mRNA synthesis. Fragments derived from the 5'-flanking region of the t-PA gene (+197 to -9578 base pairs (bp)) were linked to the chloramphenicol acetyltransferase gene. Transfection studies demonstrated that the region spanning bp -7145 to -9578 mediated induction by RA. A functional retinoic acid response element (RARE), consisting of a direct repeat of the GGGTCA motif spaced by 5 nucleotides (t-PA/DR5), was localized at -7.3 kilobases. The t-PA/DR5 element interacted with the heterodimer composed of retinoic acid receptor alpha and retinoid X receptor alpha in vitro, whereas its mutation abolished induction by RA in transient expression. In human EA.hy926 hybrid endothelial and in SK-N-SH neuroblastoma cells, the activity of t-PA/DR5 was found to be independent of the intervening sequence (-632 to -7144 bp) and of its distance from the transcription initiation site. Staurosporine, an inhibitor of protein kinase activity, inhibited induction by RA, suggesting that it required protein phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706255     DOI: 10.1074/jbc.270.13.7167

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Synergistic transcriptional activation of the mouse urokinase plasminogen activator (uPA) gene and of its enhancer activator protein 1 (AP1) site by cAMP and retinoic acid.

Authors:  R Mira-Y-Lopez; S Jaramillo; Y Jing
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

Review 2.  Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer.

Authors:  Faith Stevison; Jing Jing; Sasmita Tripathy; Nina Isoherranen
Journal:  Adv Pharmacol       Date:  2015-05-27

3.  Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma.

Authors:  Shuhei Kamada; Takeshi Namekawa; Kazuhiro Ikeda; Takashi Suzuki; Makoto Kagawa; Hideki Takeshita; Akihiro Yano; Koji Okamoto; Tomohiko Ichikawa; Kuniko Horie-Inoue; Satoru Kawakami; Satoshi Inoue
Journal:  Oncogene       Date:  2021-05-10       Impact factor: 9.867

4.  Dependence of Proximal GC Boxes and Binding Transcription Factors in the Regulation of Basal and Valproic Acid-Induced Expression of t-PA.

Authors:  Erik Ulfhammer; Pia Larsson; Mia Magnusson; Lena Karlsson; Niklas Bergh; Sverker Jern
Journal:  Int J Vasc Med       Date:  2016-02-07

5.  Effect of Regulatory Element DNA Methylation on Tissue-Type Plasminogen Activator Gene Expression.

Authors:  Sylvie Dunoyer-Geindre; Anne-Sophie Rivier-Cordey; Carlos Caetano; Richard J Fish; Egbert K O Kruithof
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

Review 6.  Towards retinoid therapy for Alzheimer's disease.

Authors:  K Shudo; H Fukasawa; M Nakagomi; N Yamagata
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

7.  Dynamic Enhancer Methylation--A Previously Unrecognized Switch for Tissue-Type Plasminogen Activator Expression.

Authors:  Mia Magnusson; Emma Xuchun Lu; Pia Larsson; Erik Ulfhammer; Niklas Bergh; Helena Carén; Sverker Jern
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

8.  Retinoids regulate human amniotic tissue-type plasminogen activator gene by a two-step mechanism.

Authors:  Valerie Borel; Geoffroy Marceau; Denis Gallot; Loïc Blanchon; Vincent Sapin
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.